Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0348321 (Haemophilus)
 15,372 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The in vitro activity of three fluorine analogs of chloramphenicol in which the hydroxyl group at position 3 had been replaced with a fluorine was compared with that of chloramphenicol and thiamphenicol. Compound SCH 24893 was the most active agent against staphylococci and Bacteroides strains, and compound SCH 25298 was the most active against Haemophilus, Neisseria, enterococcus, and Klebsiella strains. Serratia marcescens and Pseudomonas aeruginosa strains resistant to chloramphenicol were resistant to the compounds. The agents inhibited all of the Shigella, Salmonella, Staphylococcus aureus, and enterococcus strains resistant to chloramphenicol. They inhibited most (82%) of Escherichia coli and half of the Klebsiella pneumoniae strains which were resistant to chloramphenicol. Isolates in which resistance to chloramphenicol was shown to be plasmic mediated and due to chloramphenicol transacetylase were inhibited by all three agents.
 ...
PMID:In vitro activity of chloramphenicol and thiamphenicol analogs. 744 8

Haemophilus influenzae can utilize iron-loaded human transferrin as an iron source for growth in vitro. H. influenzae tonB mutants, containing a chloramphenicol acetyltransferase gene within their tonB genes, could bind iron-charged human transferrin to their cell surfaces, but they were unable to utilize this serum glycoprotein as the sole source of iron for growth in vitro. In contrast, these tonB mutants were able to utilize an iron chelate (ferric ammonium citrate) for growth. Transformation of a tonB mutant with a plasmid encoding a wild-type H. influenzae tonB gene restored the ability of a tonB mutant to utilize iron-charged human transferrin. These results indicate that the uptake of iron from human transferrin by H. influenzae is a TonB-dependent process.
 ...
PMID:Utilization of transferrin-bound iron by Haemophilus influenzae requires an intact tonB gene. 782 47

The bacteriocin haemocin is produced by most type b strains of Haemophilus influenzae, including strains of diverse genetic lineage, and is toxic to virtually all nontypeable H. influenzae strains. An H. influenzae transformant bearing a plasmid with a 1.5-kbp chromosomal fragment capable of conferring haemocin immunity on a haemocin-susceptible H. influenzae mutant was selected by using partially purified haemocin. Deletional and site-directed mutagenesis localized the haemocin immunity gene to the 3' open reading frame (ORF) within this chromosomal fragment. Subcloning of this ORF demonstrated that it was sufficient to confer haemocin immunity on wild-type haemocin-susceptible H. influenzae strains as well as haemocin-susceptible strains of Escherichia coli. This ORF, designated hmcl, encodes a 105-amino-acid protein with an estimated molecular mass of 12.6 kDa. Primer extension analysis revealed a putative transcriptional start site 34 bp upstream of the start codon, and the presence of a promoter immediately upstream of hmcI was confirmed by cloning the gene into a promoterless chloramphenicol acetyltransferase vector. To characterize the hmcI gene product, a His-HmcI fusion protein was constructed.
 ...
PMID:Cloning and characterization of the haemocin immunity gene of Haemophilus influenzae. 904 29

High antimicrobial resistance rates in Streptococcus pneumoniae has caused a need for alternative therapies. Chloramphenicol is currently being reconsidered as an empiric treatment for respiratory tract infections particularly in developing countries. In this study, we assessed the ability of the reference broth microdilution and Etest (AB BIODISK, Solna, Sweden) methods to detect chloramphenicol resistance among pneumococci as compared to the chloramphenicol acetyltransferase (CAT) assay. In the 1999 SENTRY Antimicrobial Surveillance Program, 1671 S. pneumoniae strains from respiratory tract infections were collected from 49 participants located in the Americas and Europe. The rates of penicillin and macrolide non-susceptibility were 15.6-41.3 and 12.4-26.8%, respectively. All chloramphenicol-resistant strains were CAT assay positive (n = 154; 9.2% of isolates) with highest resistance rates in Europe (12.7%; range among sites, 0.0-38.5%) and the United States (10.6%; range, 0.0-25.6%). Etest MICs correlated with reference results and the current breakpoint for chloramphenicol resistance (> or = 8 microg/mL) remains valid for S. pneumoniae and Haemophilus influenzae (eight strains tested). CAT-mediated resistances dominate among chloramphenicol-resistant S. pneumoniae, and marked geographic variations in susceptibility were discovered.
 ...
PMID:Accuracy of broth microdilution and E test methods for detecting chloramphenicol acetyl transferase mediated resistance in Streptococcus pneumoniae: Geographic variations in the prevalence of resistance in The SENTRY Antimicrobial Surveillance Program (1999). 1140 73

Antimicrobial susceptibility of 79 non-typable Haemophilus influenzae isolations obtained from healthy children that attended two day-care centers in Marianao municipality. It was found resistance to trimetoprim/sulfamethoxazole (41,77 %), tetracycline (18,99), ampicilline (17,72 %), amoxicillin/ clavulanic acid (7,59 %) and chloramphenicol (6,33 %). 25,81 % of isolates showed multiresistance. 100 % of studied cases was sensitive to ceftriaxone, cefuroxime and norfloxacin. 28,57 % of ampicilline-resistent isolates produced beta-lactamase enzyme. Chloramphenicol resistance was mediated by the production of chloramphenicol acetyltransferase enzyme.
 ...
PMID:[Antimicrobial susceptibility in non-typable Haemophilus influenzae strains isolated from healthy children]. 1584 11


<< Previous 1 2 3